Mark J. Field FRSB FIScT
30 years pharma experience to Head of R&D
Founder Analgesic Innovation
Find out more about Analgesic Innovation (Ai)
Entrepreneur scientist with over 30 years’ experience developing new medicines in Neuroscience & Pain.
Unique expertise across both preclinical research & clinical development @ Pfizer, Parke-Davis, MSD & Grunenthal.
Currently Founder/Owner of Analgesic Innovation (Ai).
Find out more about
Led the research that identified Gabapentin (Neurontin®) and Pregabalin (Lyrica®) as analgesics which generated peak annual revenues of over $5 Billion for Pfizer.
Associated with >30 compounds entering clinical trials.
Establishing NewCo developing precision-analgesics™.
for expert views on analgesic news
My Research is documented in over 100 full-length Manuscripts, Abstracts and Patents with over 4500 citations and h-index of 32. Link to published research.
Independent R&D/analgesic expert - International speaker.
Owner/Developer of digital media to increase awareness of of chronic pain to reduce the YEARS patients are waiting just for a diagnosis.
Find out more about The Pain Landscape and how more awareness can help reduce patients time to diagnosis.